Ginkgo Bioworks Holdings, Inc.

DNA

$14.82

Name : Ginkgo Bioworks Holdings, Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $877,340,288.00

EPSttm : -5.76

Ginkgo Bioworks Holdings, Inc.

$14.82

0.34%

$0.05

Float Short %

15.48

Margin Of Safety %

Put/Call OI Ratio

0.09

EPS Next Q Diff

-0.17

EPS Last/This Y

5.29

EPS This/Next Y

0.91

Price

14.83

Target Price

11.33

Analyst Recom

3.75

Performance Q

33.88

Relative Volume

0.99

Beta

1.54

Ticker: DNA

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-09-08	DNA	11.19	0.16	0.16	113057
2025-09-09	DNA	10.76	0.16	0.16	113340
2025-09-10	DNA	10.28	0.16	0.41	113266
2025-09-11	DNA	10.44	0.15	0.09	112981
2025-09-12	DNA	10	0.16	0.49	112279
2025-09-15	DNA	10.21	0.16	0.15	114343
2025-09-16	DNA	10.61	0.16	0.51	114592
2025-09-17	DNA	11.07	0.16307947858322	0.078421052631579	114832
2025-09-18	DNA	11.42	0.16	0.09	115013
2025-09-19	DNA	11.38	0.16	0.60	114530
2025-09-22	DNA	12.02	0.08	0.11	97369
2025-09-23	DNA	12.33	0.09	0.22	98832
2025-09-24	DNA	11.54	0.09	0.23	99634
2025-09-25	DNA	11.25	0.09	0.28	99899
2025-09-26	DNA	11.49	0.09	0.09	100261
2025-09-29	DNA	13.04	0.09	0.14	100369
2025-09-30	DNA	14.58	0.09	0.05	101307
2025-10-01	DNA	14.67	0.09	0.07	105170
2025-10-02	DNA	15.96	0.09	0.11	105496
2025-10-03	DNA	16.12	0.09	0.16	107273
2025-10-06	DNA	14.88	0.09	0.16	107497
2025-10-07	DNA	14.82	0.09	0.15	108057
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-09-08	DNA	11.19	-	-	-5.25
2025-09-09	DNA	10.76	-	-	-5.25
2025-09-10	DNA	10.27	-	-	-5.25
2025-09-11	DNA	10.44	-	-	-5.25
2025-09-12	DNA	9.99	-	-	-5.25
2025-09-15	DNA	10.26	-	-	-5.25
2025-09-16	DNA	10.63	-	-	-5.25
2025-09-17	DNA	11.09	-	-	-5.25
2025-09-18	DNA	11.43	-	-	-5.25
2025-09-19	DNA	11.35	-	-	-5.25
2025-09-22	DNA	12.03	-	-	-5.25
2025-09-23	DNA	12.34	-	-	-5.25
2025-09-24	DNA	11.54	-	-	-5.25
2025-09-25	DNA	11.25	-	-	-5.25
2025-09-26	DNA	11.50	-	-	-5.25
2025-09-29	DNA	13.23	-	-	-5.25
2025-09-30	DNA	14.60	-	-	-5.25
2025-10-01	DNA	14.68	-	-	-5.25
2025-10-02	DNA	15.94	-	-	-5.25
2025-10-03	DNA	16.15	-	-	-5.25
2025-10-06	DNA	14.86	-	-	-5.25
2025-10-07	DNA	14.83	-	-	-5.25
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-09-08	DNA	-0.03	3.33	17.53
2025-09-09	DNA	-0.03	3.33	17.53
2025-09-10	DNA	-0.15	3.33	17.53
2025-09-11	DNA	-0.15	3.33	16.56
2025-09-12	DNA	-0.15	3.33	16.56
2025-09-15	DNA	-0.16	3.32	16.56
2025-09-16	DNA	-0.16	3.32	16.56
2025-09-17	DNA	-0.15	3.32	16.56
2025-09-18	DNA	-0.15	3.32	16.56
2025-09-19	DNA	-0.15	3.32	16.56
2025-09-22	DNA	-0.15	3.33	16.56
2025-09-23	DNA	-0.15	3.33	16.56
2025-09-24	DNA	-0.15	3.33	16.56
2025-09-25	DNA	-0.15	3.33	15.48
2025-09-26	DNA	-0.15	3.33	15.48
2025-09-29	DNA	-0.15	3.34	15.48
2025-09-30	DNA	-0.15	3.34	15.48
2025-10-01	DNA	-0.15	3.34	15.48
2025-10-02	DNA	-0.15	3.34	15.48
2025-10-03	DNA	-0.18	3.34	15.48
2025-10-06	DNA	-0.18	2.64	15.48
2025-10-07	DNA	-0.18	2.64	15.48
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-1.1

Avg. EPS Est. Current Quarter

-1.24

Avg. EPS Est. Next Quarter

-1.27

Insider Transactions

-0.18

Institutional Transactions

2.64

Beta

1.54

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

97.7

Max Drawdown 5-Year %

Target Price

11.33

P/E

Forward P/E

PEG

P/S

3.8

P/B

1.27

P/Free Cash Flow

EPS

-5.85

Average EPS Est. Cur. Y

-5.25

EPS Next Y. (Est.)

-4.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-136.56

Relative Volume

0.99

Return on Equity vs Sector %

-76.6

Return on Equity vs Industry %

-62.9

EPS 1 7Days Diff

EPS 1 30Days Diff

0.87

EBIT Estimation

Ginkgo Bioworks Holdings, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 834

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops a platform for cell programming in the United States. It operates through Cell Engineering and Biosecurity segments. The company offers cell engineering research and development solutions, as well as cell engineering tools comprising functional genomics and antibody developability Datapoints services, artificial intelligence models, and reconfigurable automation cart systems on its platform for use in the research, development, and commercialization of engineered organisms and derived products. It also provides biomonitoring and bioinformatics support services through Canopy, which generates genomic data from strategically positioned nodes through biomonitoring programs; and Horizon, a digital surveillance, analytics, and insights platform that detects and monitors biothreats. The company serves the pharmaceutical and biotechnology, agriculture, industrial and environment, food and nutrition, consumer and technology, and government and defense industries. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

stock quote shares DNA – Ginkgo Bioworks Holdings, Inc. Stock Price stock today

news today DNA – Ginkgo Bioworks Holdings, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch DNA – Ginkgo Bioworks Holdings, Inc. yahoo finance google finance

stock history DNA – Ginkgo Bioworks Holdings, Inc. invest stock market

stock prices DNA premarket after hours

ticker DNA fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: DNA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Last Quarter Act. EPS

Average EPS Est. Cur. Y